Ocera Therapeutics names a new CFO

Ocera Therapeutics (OCRX +2.4%) says it's appointed Jeryl L. Hilleman as its new CFO, effective immediately.

Hilleman replaces Dana McGowan, who will continue with the company during a transition period in which the company plans to move its headquarters to Northern California.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs